Redmile Group, LLC Grifols Sa Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.14 - $9.29 $857,514 - $1.12 Million	-120,100 Reduced 16.66%	600,684 $5.5 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $2.63 Million - $4.22 Million	395,184 Added 121.37%	720,784 $5.31 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $1.94 Million - $2.78 Million	325,600 New	325,600 $2.77 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.